Top Reasons to Read This HEOR Teams Report
Balance short-term approval needs with long-term market access and payer needs: HEOR Teams face challenges in communicating the importance of health economics and outcomes research prior to launch, and resource prioritization is an obstacle. Botched launches in major markets can ripple through the entire market access budget. Building World-Class HEOR Teams examines how to structure and resource Health Economics & Outcomes Research groups effectively. Dedicated HEOR Teams provide the advantage of coordinating both prospective and retrospective health economics and outcomes research activities. The study also includes case studies of real-company HEOR organizational structures; these examples also show how to most effectively manage vendors for HEOR activities. Metrics include total HEOR budgets, sources of funding for HEOR activities, and funding allocation between compounds in development and marketed brands.
Use the right HEOR studies to build understanding of what is driving patient needs — and to address payer requirements: Getting an early start on developing the health economics plan for a product is crucial in meeting payer needs. Identifying comparators and understanding the competitive landscape at launch can be difficult in early phases — but groups are still able to conduct research that lays the groundwork for a product’s future success on the market. Once launch approaches and health economics and outcomes research involvement reaches its peak, companies should know how many studies are required to support a product effectively, as well as the potential budgetary pressures that come with addressing payer concerns. This report guides companies in making critical decisions and planning surrounding HEOR studies and their costs. Benchmarks include how many health economics studies are conducted and their cost and duration.
Plan to increase health outcomes liaison (HOL) headcounts as payers demand more detailed information: The study examines HEOR team staffing as well as the activities and strategies that impact their operations. Research highlights staffing numbers across central global groups and affiliate-level health economics and outcomes research teams as well as compensation structure for individual team positions. Interviewed executives explain the rising need, and increased role, for health outcomes liaisons (HOLs) to discuss pharmacoeconomic data with payers as part of a compelling value story. Other data demonstrate the core activities driving strategy across HEOR groups as well as perceived impact of health economics and outcomes data for specific payers’ formulary decisions. Altogether, the information in this report helps companies build skilled, focused HEOR Teams capable of adjusting to payer needs throughout the product lifecycle.
Key Questions That This Study Answers about Building World Class HEOR Teams
- How can my company organize our health economics and outcomes research teams to maximize their performance? How do dedicated teams enhance HEOR activities and better address payers’ needs?
- How much should companies allocate for HEOR spending per product and per development phase?
- How many FTEs are on health economics and outcomes research teams per position? What compensation levels are needed to compete for and attain top talent?
- Which HEOR studies — and how many — are needed for superior product support? How much do these studies typically cost and how long do they take?
- How do companies use HEOR to balance short-term approval needs with long-term market access goals?
- Which key performance indicators are most effective for measuring health economics and outcomes research value? What strategies do teams at leading companies use to demonstrate the importance of health economics research?
- How can teams best communicate and ensure HEOR group involvement throughout product development? How does early HEOR involvement positively impact strategic planning?
- How can companies prioritize their HEOR spending and activities to best impact payers’ pricing and formulary decisions?
- What are the advantages of increasing health economics liaison (HOL) teams to manage payers’ requests for information?
- What strategies do top companies use to coordinate efforts between field forces as they deliver information to payers?
|Publication Date||March 2015|
|Charts / Graphics||118|